Gus A. Baker

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

Anthony G Marson, Asya M Al-Kharusi, Muna Alwaidh et al. · The Lancet · 2007 · 976 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

Anthony G Marson, Asya M Al-Kharusi, Muna Alwaidh et al. · The Lancet · 2007 · 970 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Quality of Life of People with Epilepsy: A European Study

Gus A. Baker, Ann Jacoby, Deborah Buck et al. · Epilepsia · 1997 · 841 citations

Medicine, Neurology, Behavioral Health +12

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

Kimford J. Meador, Gus A. Baker, N. Andrew Browning et al. · The Lancet Neurology · 2013 · 831 citations · Full text

Medicine, Neurology, Pediatrics +17

Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs

Kimford J. Meador, Gus A. Baker, N. Andrew Browning et al. · New England Journal of Medicine · 2009 · 818 citations · Full text

Medicine, Neuroscience, Pediatrics +17